Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.

Notably, while Imip treatment showed a reduction in IL-6 expression, this reduction did not reach statistical significance ( Figure 5 D,E).

also in 111,027 other papers